Changes in lipid profile parameters and PON1 status associated with L55M PON1 polymorphism, overweight and exposure to tobacco smoke

References

• Alleva R, Manzella N, Gaetani S, et al. (2018). Mechanism underlying the effect of long-term exposure to low dose of pesticides on DNA integrity. Environ Toxicol 33:476–87.
   PubMed Web of Science ®Google Scholar
• Bizoń A, Kepinska M, Snacki K, Milnerowicz H. (2016). The impact of environmental and biological factors on paraoxonase 1 and γ-glutamyltranspeptydase activities in the blood of smelters. Int J Environ Health Res 26:222–38.
   PubMed Web of Science ®Google Scholar
• Bizoń A, Milnerowicz H. (2017). The effect of passive and active exposure to tobacco smoke on lipid profile parameters and the activity of certain membrane enzymes in the blood of women in the first trimester of pregnancy. Environ Toxicol Pharmacol 53:74–80.
   PubMed Web of Science ®Google Scholar
• Bizoń A, Milnerowicz H. (2018). The effect of divalent metal chelators and cadmium on serum phosphotriesterase, lactonase and arylesterase activities of paraoxonase 1. Environ Toxicol Pharmacol 58:77–83.
   PubMed Web of Science ®Google Scholar
• Borges MD, Franca EL, Fujimori M, et al. (2018). Relationship between Proinflammatory Cytokines/Chemokines and Adipokines in Serum of Young Adults with Obesity. Endocr. Metab. Immune Disord. Drug Targets 18:260–7.
   PubMed Web of Science ®Google Scholar
• Camps J, Marsillach J, Joven J. (2009). Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World J Gastroenterol 15:1929–33.
   PubMed Web of Science ®Google Scholar
• Camps J, Rodríguez-Gallego E, García-Heredia A, et al. (2014). Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases. Adv Clin Chem 63:247–308.
   PubMed Web of Science ®Google Scholar
• Ceron JJ, Tecles F, Tvarijonaviciute A. (2014). Serum paraoxonase 1 (PON1) measurement: an update. BMC Vet Res 10:74.
   PubMed Web of Science ®Google Scholar
• Chen H, Ding S, Zhou M, et al. (2018). PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia: clinical study of possible associations. Herz 43:642–8.
   Google Scholar
• Chen Q, Reis SE, Kammerer CM, WISE Study Group, et al. (2003). Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Am J Hum Genet 72:13–22.
   PubMed Web of Science ®Google Scholar
• Draganov DI, Stetson PL, Watson CE, et al. (2000). Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275:33435–42.
   PubMed Web of Science ®Google Scholar
• Draganov DI, Teiber JF, Speelman A, et al. (2005). Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 46:1239–47.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Beydemir S. (2009). Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases. Eur J Pharmacol 617:84–9.
   PubMed Web of Science ®Google Scholar
• Eom S-Y, Kim Y-S, Lee C-J, et al. (2011). Effects of intronic and exonic polymorphisms of paraoxonase 1 (PON1) gene on serum PON1 activity in a Korean population. J Korean Med Sci 26:720.
   PubMed Web of Science ®Google Scholar
• Gamboa R, Zamora J, Rodríguez-Pérez JM, et al. (2006). Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile. Exp Mol Pathol 80:85–90.
   PubMed Web of Science ®Google Scholar
• Garin MC, James RW, Dussoix P, et al. (1997). Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62–6.
   PubMed Web of Science ®Google Scholar
• Grdić M, Barisić K, Rumora L, et al. (2008). Genetic frequencies of paraoxonase 1 gene polymorphisms in Croatian population. Croat Chem Acta 81:105–11.
   Web of Science ®Google Scholar
• Grubisa I, Otasević P, Dimković N, et al. (2013). Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis. Srp Arh Celok Lek 141:629–33.
   PubMed Web of Science ®Google Scholar
• Iwanicka J, Iwanicki T, Niemiec P, et al. (2017). Relationship between rs854560 PON1 Gene Polymorphism and Tobacco Smoking with Coronary Artery Disease. Dis Markers 2017:1540949.
   PubMedGoogle Scholar
• Mackness B, Davies GK, Turkie W, et al. (2001). Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21:1451–7.
   PubMed Web of Science ®Google Scholar
• Mackness B, Mackness MI, Arrol S, et al. (1998). Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341–9.
   PubMed Web of Science ®Google Scholar
• Mackness M, Mackness B. (2015). Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene 567:12–21.
   PubMed Web of Science ®Google Scholar
• Marsillach J, Costa LG, Furlong CE. (2016). Paraoxonase-1 and early-life environmental exposures. Ann Glob Health 82:100–10.
   PubMed Web of Science ®Google Scholar
• Milnerowicz H, Kowalska K, Socha E. (2015). Paraoxonase activity as a marker of exposure to xenobiotics in tobacco smoke. Int J Toxicol 34:224–32.
   PubMed Web of Science ®Google Scholar
• Mitra S, Kshatriya GK. (2016). Genetic variation at Q192R and L55M polymorphisms in PON1. Environ Toxicol Pharmacol 45:251–6.
   PubMed Web of Science ®Google Scholar
• Motovali-Bashi M, Sedaghat S, Dehghanian F. (2015). Association between serum paraoxonase 1 activities (PONase/AREase) and L55M polymorphism in risk of female infertility. Avicenna J Med Biotechnol 7:173–8.
   PubMedGoogle Scholar
• Paul KC, Sinsheimer JS, Cockburn M, et al. (2017). Organophosphate pesticides and PON1 L55M in Parkinson’s disease progression. Environ Int 107:75–81.
   PubMed Web of Science ®Google Scholar
• Perła-Kaján J, Jakubowski H. (2012). Paraoxonase 1 and homocysteine metabolism. Amino Acids 43:1405–17.
   PubMed Web of Science ®Google Scholar
• Rajkovic MG, Rumora L, Barisic K. (2011). The paraoxonase 1, 2 and 3 in humans. Biochem Med (Zagreb) 21:122–30.
   PubMed Web of Science ®Google Scholar
• Reed RM, Borgan SM, Eberlein M, et al. (2017). Tobacco smoke exposure reduces paraoxonase activity in a murine model. Int J Biomed Sci IJBS 13:20–5.
   PubMedGoogle Scholar
• Richter RJ, Jarvik GP, Furlong CE. (2010). Paraoxonase 1 status as a risk factor for disease or exposure. Adv Exp Med Biol 660:29–35.
   PubMed Web of Science ®Google Scholar
• Rosenblat M, Gaidukov L, Khersonsky O, et al. (2006). The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 281:7657–65.
   PubMed Web of Science ®Google Scholar
• She Z-G, Chen H-Z, Yan Y, et al. (2012). The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal 16:597–632.
   PubMed Web of Science ®Google Scholar
• Smolen A, Eckerson HW, Gan KN, et al. (1991). Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. Drug Metab Dispos Biol Fate Chem 19:107–12.
   PubMed Web of Science ®Google Scholar
• Srisurin W. (2014). The reliability of calculated low-density lipoprotein cholesterol from four different formulas in Thai diabetic patients. J Med Assoc Thail Chotmaihet Thangphaet 97:589–97.
   PubMedGoogle Scholar
• Tajbakhsh A, Rezaee M, Rivandi M, et al. (2017). Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation. Clin Biochem 50:1298–305.
   PubMed Web of Science ®Google Scholar
• Tang WHW, Hartiala J, Fan Y, et al. (2012). Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol 32:2803–12.
   PubMed Web of Science ®Google Scholar
• Vargas HO, Nunes SOV, Barbosa DS, et al. (2014). Castelli Risk Indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci 102:65–71.
   PubMed Web of Science ®Google Scholar
• Veiga L, Silva-Nunes J, Melão A, et al. (2011). Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women. Eur J Endocrinol 164:213–8.
   PubMed Web of Science ®Google Scholar
• Zaki ME, El-Bassyouni H, Kamal S, et al. (2014). Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents. Indian J Endocrinol Metab 18:340–4.
   PubMedGoogle Scholar